Zydus Cadila gets USFDA nod for Isosorbide Dinitrate tablets, Desonide Cream

The USFDA has approved to market Isosorbide Dinitrate tablets manufactured by drug firm Zydus Cadila. The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin conditions like eczema, dermatitis, allergies and rash, the company said in a filing to BSE.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news